W.G. Shaheen & Associates Dba Whitney & CO Heron Therapeutics, Inc. Transaction History

W.G. Shaheen & Associates Dba Whitney & CO

$856 Million
Q2 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2018 Feb 07, 2019	SELL	$22.03 - $32.01 $991 - $1,440	-45 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$30.0 - $40.85 $1,350 - $1,838	45 New	45 $1,000

Others Institutions Holding HRTX

# of Institutions

193

Shares Held

129M

Call Options Held

94.7K

Put Options Held

148K

Rubric Capital Management LP New York, NY

26.7M
Shares

$51 Million
2.77% of portfolio
Vanguard Group Inc Valley Forge, PA

8.62M
Shares

$16.5 Million
0.0% of portfolio
Black Rock Inc. New York, NY

8.33M
Shares

$15.9 Million
0.0% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

7.6M
Shares

$14.5 Million
0.05% of portfolio
Velan Capital Investment Management LP Alpharetta, GA

6.99M
Shares

$13.3 Million
58.47% of portfolio

View Full List

About HERON THERAPEUTICS, INC.

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $227M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

More about HRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of W.G. Shaheen & Associates Dba Whitney & CO, based on Form 13F filings with the SEC.

News

Stay updated on W.G. Shaheen & Associates Dba Whitney & CO with notifications on news.

Account